Tagged: sanotize

August 24, 2022 @ 11:07 am By JD Alois  |  

SaNOtize has raised $24 million in Series B funding in a rojnd led by global investment crowdfunding platform OurCrowd and Horizons Ventures. The Agricultural Bank of China International also participated in the funding round. OurCrowd enables accredited investors to gain access to unique venture capital… Read More

February 9, 2022 @ 7:08 pm By JD Alois  |  

SaNOtize, an OurCrowd portfolio company, has shown to be 99% effective against COVID-19 in a phase three trial, according to a note distributed by OurCrowd. Simultaneously, the treatment has received regulatory approval in India. OurCrowd has participated in the funding of the firm providing access… Read More

March 22, 2021 @ 7:03 am By JD Alois  |  

OurCrowd portfolio company SaNOtize Research & Development Corp. has received interim approval to sell its COVID-19 treatment Nitric Oxide Nasal Spray (NONS). The spray is said to protect users from viruses that enter the body through the upper nasal pathways. The spray will be sold… Read More

March 15, 2021 @ 10:09 pm By JD Alois  |  

OurCrowd portfolio company SaNOtize says that a UK clinical trial has delivered solid results as COVID-19 treatment. A self-administered nasal spray is said to reduce the viral load by more than 95% in 24 hours and by 99% in 72 hours. Trial results indicated that… Read More